top of page

PBYI

Puma Biotechnology

Price

chg

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

low api

52 wk hi

high api

Cash

$73.9M

Burn Rate (Qtr)

$26.9M

Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Loading Catalysts...

search in progress

Pipeline powered by

PBYI

BPIQ_Logo_RGB-01.jpg

Company Profile

At Puma Biotechnology, our focus is on bringing innovative therapies to patients to enhance cancer care.

We are thankful to be part of the HER2+ breast cancer community and are passionate about evaluating options that may benefit patients across the breast cancer therapy spectrum.

Recent Posts

See what the community is saying - click to see full post.

June 2022 Big Mover™ Stocks and Movers to Watch Report

ASCO 2022 Annual Meeting (American Society of Clinical Oncology) - Clinical Trial Presentations

SABCS Presenters - Updated

San Antonio Breast Cancer Symposium 2021 - Investor Hub

ASCO 2021 Investor Hub - Presented Posters

ASCO 2021 Investor Hub - Updated

bottom of page